Other Clinical Trial - Danish Angle Closure Prevention Trial

Clinical Trial Description

Prospective, randomised paired-eye design clinical trial comparing peripheral laser iridotomy in one eye with observation in the other over 5-years follow-up. ;

Study Design

Related Conditions & MeSH terms

Glaucoma
Primary Angle Glaucoma Closure Suspect

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04741919` - Superior vs Temporal Laser Peripheral Iridotomy in Primary Angle Closure Suspects (PACS)	N/A
	Completed	`NCT04972435` - Effect of Multifocal Intraocular Lens on Contrast Sensitivity in Primary Angle-Closure Patients	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT04741919 - Superior vs Temporal Laser Peripheral Iridotomy in Primary Angle Closure Suspects (PACS)

N/A

Completed

NCT04972435 - Effect of Multifocal Intraocular Lens on Contrast Sensitivity in Primary Angle-Closure Patients

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06077253
Study type	Interventional
Source	University of Aarhus
Contact	Niklas Telinius, PhD, DMSc
Phone	+4530238533
Email	telinius@me.com
Status	Recruiting
Phase	N/A
Start date	September 1, 2023
Completion date	September 1, 2029

Danish Angle Closure Prevention Trial — DAP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms